Skip to main content
1-877-936-8422
VICC
Search
Main navigation
Home
Patient Care
Cancer Care Overview
Find a Doctor
Request an Appointment
Find a Clinical Trial
MyHealth at Vanderbilt
Support & Education
Cancer Information
Clinical Trials
Clinical Trials Overview
Frequently Asked Questions
Trial Search for Physicians
Trial Search For Patients
Flowcharts
Research
Research Overview
Research Programs
Shared Resources
Clinical Trials
Member Directory
Membership Information
Funding Opportunities
Seminars & Lectures
Giving
Giving & Impact
Make a Gift
Donor-Supported Research
Volunteer
Community
Community Overview
Advocacy
VICC Ambassadors
Education
Education, Training, and Career Development
Annual Scientific Retreat
About
About Vanderbilt-Ingram
Leadership
Fast Facts
History
Careers
For Media
More
Intranet (for faculty and staff)
About the site
Help
Contact the web team
Prices
Search
at Vanderbilt-Ingram Cancer Center
Site Search
All
Pages
Members
Clinical Trials
News
1031 results found
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Relevance:
1
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Relevance:
1
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Relevance:
1
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Relevance:
1
Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Relevance:
1
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Relevance:
1
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Relevance:
1
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Relevance:
1
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
Relevance:
1
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Relevance:
1
Pagination
Previous page
‹ previous
…
Page
48
Page
49
Page
50
Page
51
Current page
52
Page
53
Page
54
Page
55
Page
56
…
Next page
next ›